Gu Kong
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 7
- Geriatrics and Gerontology top 2%
- Oncology top 2%
- Cancer Cells and Metastasis 15
- Cancer-related Molecular Pathways 9
- HER2/EGFR in Cancer Research 8
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 20
- Cancer-related gene regulation 8
- Histone Deacetylase Inhibitors Research 6
- Biochemistry top 5%
-
- Estrogen and related hormone effects 7
- Co-authors
- Jeong‐Yeon LeeMi‐Ock LeeYoung‐Gun YooHeekyoung ChungSeok Jin NamHee‐Young WonYoung‐Ha OhHee‐Joo Choi
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Gu Kong
100 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 932
- Geriatrics and Gerontology 171
- Oncology 1.1k
- Molecular Biology 2.7k
- Biochemistry 130
Countries citing papers authored by Gu Kong
This map shows the geographic impact of Gu Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gu Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gu Kong more than expected).
Fields of papers citing papers by Gu Kong
This network shows the impact of papers produced by Gu Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gu Kong. The network helps show where Gu Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gu Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2023 | 6 | |
| 3 | 2020 | 50 | |
| 4 | 2017 | 76 | |
| 5 | 2017 | 54 | |
| 6 | 2014 | 22 | |
| 7 | 2013 | 100 | |
| 8 | 2011 | 48 | |
| 9 | 2010 | 2 | |
| 10 | 2010 | 12 | |
| 11 | 2010 | 9 | |
| 12 | 2008 | 26 | |
| 13 | 2006 | 38 | |
| 14 | 2006 | 91 | |
| 15 | 2006 | 50 | |
| 16 | 2006 | 25 | |
| 17 | 2006 | 45 | |
| 18 | 2005 | 9 | |
| 19 | Role of Immune-Inflammatory Mechanisms in Alzheimer's Disease and Other Degenerative Diseases | 2002 | 2 |
| 20 | 2001 | 3 |
About Gu Kong
Gu Kong is a scholar working on Cancer Research, Oncology, Molecular Biology, Pharmacology and Genetics, having authored 101 papers that have together received 4.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (20 papers), Cancer Cells and Metastasis (15 papers), Cancer-related Molecular Pathways (9 papers), HER2/EGFR in Cancer Research (8 papers), Cancer-related gene regulation (8 papers), Estrogen and related hormone effects (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). The work is most often cited by research in Cancer Research (932 citations), Geriatrics and Gerontology (171 citations), Oncology (1.1k citations), Molecular Biology (2.7k citations) and Biochemistry (130 citations). Gu Kong has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Jeong‐Yeon Lee, Mi‐Ock Lee, Young‐Gun Yoo, Heekyoung Chung, Seok Jin Nam, Hee‐Young Won, Young‐Ha Oh, Hee‐Joo Choi, Myeong Hee Moon and Kyung‐Sun Kang. Their work appears in journals such as Cancer Letters, Oncogene, Cancer Research, Toxicology and Applied Pharmacology and Toxicology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.